Mavacamten
Mavacamten
Mavacamten (pronounced as ma-va-CAM-ten) is a type of medication specifically designed to treat certain cardiovascular diseases, particularly symptomatic, obstructive hypertrophic cardiomyopathy (HCM).
Etymology
The name "Mavacamten" is derived from the drug's mechanism of action. "Mava" is short for "myosin ATPase", a key enzyme in muscle contraction, and "camten" is derived from the Latin word "campto", meaning "to bend". This refers to the drug's ability to inhibit the myosin ATPase, thereby reducing the force of heart muscle contractions and relieving symptoms of HCM.
Usage
Mavacamten is used in the treatment of symptomatic, obstructive hypertrophic cardiomyopathy (HCM). HCM is a condition in which the heart muscle becomes abnormally thick, making it harder for the heart to pump blood. Mavacamten works by reducing the ability of the heart muscle to contract, thereby reducing the symptoms associated with HCM.
Related Terms
- Myosin ATPase: An enzyme that plays a crucial role in muscle contraction.
- Hypertrophic Cardiomyopathy: A condition characterized by abnormal thickening of the heart muscle.
- Cardiovascular Diseases: A class of diseases that involve the heart or blood vessels.
- Medication: Substances used to diagnose, cure, treat, or prevent diseases.
See Also
External links
- Medical encyclopedia article on Mavacamten
- Wikipedia's article - Mavacamten
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski